Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cox

Showing results (201-210 of 212) with videos related to

Pageof 22
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 15, 2011
The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS)David R Cheshire, Anders Åberg, Gunilla M K Andersson, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 16, 2020
SCAI publications committee manual of standard operating proceduresMolly Szerlip, Dmitriy N Feldman, Herbert D Aronow, et al.
Oncology Reports|July 5, 2011
Genetic variability of the forkhead box O3 and prostate cancer risk in the European Prospective Investigation on CancerDaniele Campa, Anika Hüsing, Lucie Dostal, et al.
American Journal of Epidemiology|March 31, 2012
Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate Cancer Cohort ConsortiumKonstantinos K Tsilidis, Ruth C Travis, Paul N Appleby, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 5, 2011
Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control studyRebecca E James, Annekatrin Lukanova, Laure Dossus, et al.
JACC. Cardiovascular Imaging|August 9, 2020
Cardiac Imaging in the Post-ISCHEMIA Trial Era: A Multisociety ViewpointLeslee Shaw, Raymond Y Kwong, Eike Nagel, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 13, 2012
Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)Sara Lindström, Fredrick R Schumacher, David Cox, et al.
Breast Cancer Research : BCR|May 16, 2012
Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort studyRebecca Ritte, Annekatrin Lukanova, Franco Berrino, et al.
Journal of the National Cancer Institute|April 11, 2014
Dietary fat intake and development of specific breast cancer subtypesSabina Sieri, Paolo Chiodini, Claudia Agnoli, et al.
Nature Genetics|September 29, 2014
Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphomaJames R Cerhan, Sonja I Berndt, Joseph Vijai, et al.
Pageof 22

Showing results (201-210 of 212) with videos related to

Sort By:
Pageof 22
Bioorganic & Medicinal Chemistry Letters|March 15, 2011
The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS)David R Cheshire, Anders Åberg, Gunilla M K Andersson, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 16, 2020
SCAI publications committee manual of standard operating proceduresMolly Szerlip, Dmitriy N Feldman, Herbert D Aronow, et al.
Oncology Reports|July 5, 2011
Genetic variability of the forkhead box O3 and prostate cancer risk in the European Prospective Investigation on CancerDaniele Campa, Anika Hüsing, Lucie Dostal, et al.
American Journal of Epidemiology|March 31, 2012
Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate Cancer Cohort ConsortiumKonstantinos K Tsilidis, Ruth C Travis, Paul N Appleby, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 5, 2011
Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control studyRebecca E James, Annekatrin Lukanova, Laure Dossus, et al.
JACC. Cardiovascular Imaging|August 9, 2020
Cardiac Imaging in the Post-ISCHEMIA Trial Era: A Multisociety ViewpointLeslee Shaw, Raymond Y Kwong, Eike Nagel, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 13, 2012
Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)Sara Lindström, Fredrick R Schumacher, David Cox, et al.
Breast Cancer Research : BCR|May 16, 2012
Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort studyRebecca Ritte, Annekatrin Lukanova, Franco Berrino, et al.
Journal of the National Cancer Institute|April 11, 2014
Dietary fat intake and development of specific breast cancer subtypesSabina Sieri, Paolo Chiodini, Claudia Agnoli, et al.
Nature Genetics|September 29, 2014
Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphomaJames R Cerhan, Sonja I Berndt, Joseph Vijai, et al.
Pageof 22